Risperdal Gynecomastia Lawsuit
In September of 2012, Johnson & Johnson, the maker of Risperdal, settled the first lawsuit alleging that its drug caused gynecomastia. The young man at the heart of the case began using Risperdal at the age of 9. As a result, he alleged, he developed breasts which caused him significant psychological trauma.
Since this first Risperdal settlement, more lawsuits have been filed. Plaintiffs in these cases are seeking compensation from the manufacturer for gynecomastia and the emotional pain that accompanies it.
Families pursuing Risperdal lawsuits have varying goals for their litigation: some hope that settlements could pay for corrective surgery that insurance has refused to cover. Others simply hope that their suits will raise awareness about the risks of this antipsychotic drug for adolescent boys.
The lawsuits being filed allege, among other claims, that drug companies:
- Failed to investigate the accuracy of Risperdal label, even after they became aware of potential safety issues
- Knew, or should have known, that using Risperdal for an extended period of time increased the risk of gynecomastia
- Failed to conduct and report post-market safety studies on this drug
Our law firm believes that Johnson & Johnson, the maker of Risperdal, should be held accountable for any harm it has caused to young men who took this drug. Our Risperdal lawsuit attorneys are here to advocate for our clients and are dedicated to securing compensation for their injuries.
If you or your child has been affected by gynecomastia, or unusual breast growth, after taking Risperdal, please contact us for a no-cost consultation. Call us today at 1-888-210-9968.